Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®

REYKJAVIK, ICELAND and LONDON, UK (August 21, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwid...

When is the expected commercial launch in Europe, and what potential reimbursement or payer hurdles could delay adoption? What pricing strategy will be adopted for Mynzepli® compared to the originator Eylea® and other biosimilars, and how might that impact market share? How will the European approval of Mynzepli® affect Alvotech's and Advanz Pharma's revenue forecasts and stock valuations?
Symbol: ALVO
Approval
21 days ago
Read more globenewswire

VNET Reports Unaudited Second Quarter 2025 Financial Results

BEIJING, Aug. 21, 2025 /PRNewswire/ -- VNET Group, Inc. (Nasdaq: VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral internet data center services provider in China, today announc...

How does VNET's growth trajectory, utilization rates, and capital spending compare to its key competitors in the Chinese data center market? What guidance or outlook did VNET provide for the remainder of 2025 and FY2025, and how might that influence the stock's valuation? How did VNET's Q2 revenue, earnings, and margin numbers compare to analyst expectations and the prior quarter?
Symbol: VNET
Earnings
21 days ago
Read more prnewswire

Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®

REYKJAVIK, Iceland and LONDON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for pati...

What are the potential revenue and margin implications for both companies over the next 12‑18 months? What market share can Alvotech realistically capture from Eylea® competitors with this biosimilar launch? How will the European approval of Mynzepli® affect Alvotech and Advanz Pharma's share price in the short term?
Symbol: ALVO
Regulatory
21 days ago
Read more globenewswire

Valmet to supply two papermaking lines to a customer in China

Valmet Oyj's press release, August 21, 2025, at 11:00 a.m. EEST ESPOO, Finland, Aug. 21, 2025 /PRNewswire/ -- Valmet is to supply two fine papermaking lines with related automation systems and serv...

What are the anticipated margins and cash flow implications of supplying these papermaking lines, including any required upfront investments or financing terms? How does this order compare to recent contracts secured by Valmet's peers in the Chinese papermaking equipment market? What is the total contract value and its expected contribution to Valmet's revenue and earnings in the upcoming quarters?
Symbol: VALMT
Orders
21 days ago
Read more prnewswire

KLC Investors Have Opportunity to Lead KinderCare Learning Companies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, Aug. 21, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against KinderCare Learning Companies, ...

What precedent do similar securities‑fraud lawsuits have on comparable education‑sector stocks and what timeline can be expected for resolution? How large could potential liabilities or settlement costs be and how might they affect earnings guidance? What is the expected short‑term impact on KLC’s share price and volatility?
Symbol: KLC
Lawsuits
21 days ago
Read more prnewswire

TLX Investors Have Opportunity to Join Telix Pharmaceuticals Limited Fraud Investigation with the Schall Law Firm

LOS ANGELES, Aug. 21, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Telix Pharmaceutic...

What are the potential financial and operational ramifications for Telix if the investigation confirms securities‑law violations, and how could this impact its competitive standing and long‑term valuation? What is the expected timeline for the investigation and potential resolution, and how might that timeline influence market positioning? How will the fraud investigation affect TLX's short‑term stock volatility and price direction?
Symbol: TLX
Lawsuits
21 days ago
Read more prnewswire